Nextkidney raises €11.9M in Series B round
Portfolio company Nextkidney closes €11.9M Series B to accelerate development of the NeoKidney — the world's first truly portable home hemodialysis device.
Nextkidney, the Dutch MedTech company developing the NeoKidney — the world’s first portable home hemodialysis device — closed a Series B funding round of €11.9 million in February 2023.
The round combined €7.8M from professional and informal investors in France and the Netherlands with a crowdfunding component. The capital will be used to accelerate development and commercialisation of the NeoKidney device, which aims to give kidney patients the freedom to dialyse at home without the burden of large, fixed equipment.
Why Commit Capital has been an early backer of Nextkidney, backing the team’s vision to fundamentally improve quality of life for hemodialysis patients worldwide.